MARKET WIRE NEWS

Overweight Recommendation Issued On RGNX By Morgan Stanley

Source: KlickAnalytics

2026-03-05 16:15:05 ET

  • Morgan Stanley analyst issues OVERWEIGHT recommendation for RGNX on March 5, 2026 07:52PM ET.
  • The previous analyst recommendation was Overweight.
  • RGNX was trading at $8.72 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 1 - Strong Buy, 13 - Buy, 5 - Hold, 1 - Sell recommendations .

  • Historical Analyst Recommendations

    Full story available on KlickAnalytics.com
    REGENXBIO Inc.

    NASDAQ: RGNX

    RGNX Trading

    25.68% G/L:

    $10.57 Last:

    984,362 Volume:

    $9.75 Open:

    mwn-ir Ad 300

    RGNX Latest News

    RGNX Stock Data

    $434,346,078
    44,148,393
    1.97%
    52
    N/A
    Biotechnology & Life Sciences
    Healthcare
    US
    Rockville

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App